Pharmacological Management for Pediatric Pneumonia
First-Line Outpatient Treatment
Amoxicillin 90 mg/kg/day divided into 2 doses is the definitive first-line antibiotic for outpatient treatment of pediatric community-acquired pneumonia in children over 3 months of age. 1, 2, 3
Age-Specific Dosing
- Children <5 years: Amoxicillin 90 mg/kg/day in 2 divided doses (maximum 4 g/day) 2, 3
- Children ≥5 years: Amoxicillin 90 mg/kg/day in 2 divided doses (maximum 4 g/day) 2, 3
- If atypical pathogens suspected (age ≥5 years): Add azithromycin 10 mg/kg on day 1, then 5 mg/kg/day on days 2-5 2, 3, 4
Critical Dosing Pitfall
The high-dose amoxicillin regimen (90 mg/kg/day) is essential to overcome pneumococcal resistance—underdosing with 40-45 mg/kg/day is a common and dangerous error. 2 This higher dose provides adequate time above the MIC for resistant Streptococcus pneumoniae strains. 1
Special Populations
- Not fully immunized against H. influenzae type b or S. pneumoniae: Use amoxicillin-clavulanate (amoxicillin component 90 mg/kg/day in 2 doses) instead of amoxicillin alone to cover β-lactamase-producing H. influenzae 2, 3
- Suspected MRSA involvement: Add clindamycin 30-40 mg/kg/day in 3-4 doses to the β-lactam regimen 1, 2
Inpatient Treatment Algorithm
Fully Immunized, Low-Risk Children
Preferred: Intravenous ampicillin 150-200 mg/kg/day every 6 hours OR penicillin G 100,000-250,000 U/kg/day every 4-6 hours 1, 2, 3
Alternative: Ceftriaxone 50-100 mg/kg/day every 12-24 hours OR cefotaxime 150 mg/kg/day every 8 hours 1, 2
Not Fully Immunized or High-Risk Children
Preferred regimen: Ceftriaxone 50-100 mg/kg/day every 12-24 hours OR cefotaxime 150 mg/kg/day every 8 hours PLUS vancomycin 40-60 mg/kg/day every 6-8 hours OR clindamycin 40 mg/kg/day every 6-8 hours 1, 2
This combination addresses potential resistant organisms and provides MRSA coverage. 2
Atypical Pneumonia (Hospitalized)
Preferred: Intravenous azithromycin 10 mg/kg on days 1 and 2, then transition to oral therapy 1, 3
Alternative: Erythromycin lactobionate 20 mg/kg/day IV every 6 hours 1
Pathogen-Specific Treatment
Streptococcus pneumoniae
- Outpatient: Amoxicillin 50-75 mg/kg/day in 2 doses (or 90 mg/kg/day for resistant strains) 1, 3
- Inpatient: Ampicillin 200 mg/kg/day every 6 hours OR penicillin G 100,000-250,000 U/kg/day every 4-6 hours 1
- Alternative: Clindamycin 40 mg/kg/day every 6-8 hours if susceptible 1, 5
Staphylococcus aureus (MSSA)
- Outpatient: Amoxicillin-clavulanate (amoxicillin component 90 mg/kg/day in 2 doses) 2
- Inpatient: Cefazolin 150 mg/kg/day every 8 hours OR oxacillin 150-200 mg/kg/day every 6-8 hours 1
- Oral step-down: Cephalexin 75-100 mg/kg/day in 3-4 doses 1
MRSA (Clindamycin-Susceptible)
- Outpatient: Clindamycin 30-40 mg/kg/day in 3-4 doses 1, 5, 2
- Inpatient: Vancomycin 40-60 mg/kg/day every 6-8 hours (target AUC/MIC >400) OR clindamycin 40 mg/kg/day every 6-8 hours 1, 5
- Important caveat: Only use clindamycin if local MRSA resistance rates are <10% 5
MRSA (Clindamycin-Resistant)
- Inpatient: Vancomycin 40-60 mg/kg/day every 6-8 hours 1, 5
- Oral step-down: Linezolid 30 mg/kg/day in 3 doses for children <12 years; 20 mg/kg/day in 2 doses for children ≥12 years 1, 5
Haemophilus influenzae
- β-lactamase negative: Amoxicillin 75-100 mg/kg/day in 3 doses 1, 3
- β-lactamase producing: Amoxicillin-clavulanate (amoxicillin component 45 mg/kg/day in 3 doses OR 90 mg/kg/day in 2 doses) 1, 3
- Inpatient: Ceftriaxone 50-100 mg/kg/day every 12-24 hours OR cefotaxime 150 mg/kg/day every 8 hours 1
Mycoplasma pneumoniae / Chlamydophila pneumoniae
- Outpatient: Azithromycin 10 mg/kg on day 1, then 5 mg/kg/day once daily on days 2-5 1, 3, 4
- Inpatient: Azithromycin IV 10 mg/kg on days 1 and 2, then transition to oral 1, 3
- Alternative (age >7 years): Doxycycline 2-4 mg/kg/day in 2 doses 1
Group A Streptococcus
- Outpatient: Amoxicillin 50-75 mg/kg/day in 2 doses OR penicillin V 50-75 mg/kg/day in 3-4 doses 1
- Inpatient: Penicillin G 100,000-250,000 U/kg/day every 4-6 hours OR ampicillin 200 mg/kg/day every 6 hours 1
- Alternative: Clindamycin 40 mg/kg/day in 3 doses (oral) or every 6-8 hours (IV) 1, 5
Penicillin Allergy Management
Non-Severe Allergic Reactions
Consider oral cephalosporins with substantial activity against S. pneumoniae under medical supervision: 2, 3
- Cefpodoxime
- Cefprozil
- Cefuroxime
Severe Allergic Reactions (Anaphylaxis)
- Levofloxacin 16-20 mg/kg/day every 12 hours (children 6 months to 5 years); 8-10 mg/kg/day once daily (children 5-16 years; maximum 750 mg/day) 1
- Linezolid (dosing as above for MRSA)
Note: Macrolides may be considered but have higher resistance rates. 2
Treatment Duration and Monitoring
Expected Clinical Response
Children should demonstrate clinical improvement within 48-72 hours of starting appropriate therapy. 2, 3 If no improvement occurs within this timeframe, reassess for:
- Inadequate source control (parapneumonic effusion requiring drainage) 2
- Resistant organisms 2
- Alternative diagnosis 3
Duration of Therapy
- Uncomplicated pneumonia: 5-7 days total (oral therapy) 5, 6
- Severe pneumonia: 7-14 days depending on clinical response 5
- MRSA pneumonia: 7-21 days depending on extent of infection 5
- Complicated infections (empyema, necrotizing pneumonia): Extended courses may be required 5
Step-Down Criteria
Transition from IV to oral therapy when: 5
- Clinical improvement evident (decreased fever, improved respiratory status)
- Able to tolerate oral intake
- At least 48 hours of IV therapy completed
Key Clinical Considerations
Antimicrobial Stewardship Principles
- Use the narrowest spectrum antibiotic effective against the presumed pathogen 3
- Limit antibiotic exposure to prevent resistance development 3
- Ensure proper dosing to achieve adequate drug concentrations at the infection site 3
- Complete the full prescribed course even if symptoms improve 3
Common Pitfalls to Avoid
- Underdosing amoxicillin (using 40-45 mg/kg/day instead of 90 mg/kg/day) 2
- Inappropriate use of macrolides as first-line therapy for presumed bacterial pneumonia 2
- Failure to consider MRSA in severe pneumonia with risk factors 2
- Using clindamycin in areas with >10% MRSA resistance 5
- Not obtaining cultures before starting antibiotics in hospitalized patients 2
When to Obtain Pleural Fluid
If significant parapneumonic effusion is present, obtain pleural fluid for Gram stain and culture to guide targeted therapy. 2